Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-12,630
Closed -$654K 370
2025
Q2
$654K Buy
+12,630
New +$580K 0.14% 184
2022
Q1
Sell
-8,027
Closed -$409K 747
2021
Q4
$409K Buy
+8,027
New +$380K 0.07% 330
2021
Q3
Sell
-5,144
Closed -$224K 593
2021
Q2
$224K Sell
5,144
-6,604
-56% -$310K 0.05% 426
2021
Q1
$532K Sell
11,748
-17,357
-60% -$727K 0.11% 274
2020
Q4
$1.04M Buy
+29,105
New +$842K 0.22% 152
2019
Q2
Sell
-40,363
Closed -$1.43M 453
2019
Q1
$1.43M Buy
+40,363
New +$1.48M 0.51% 66
2018
Q4
Sell
-8,041
Closed -$299K 342
2018
Q3
$299K Buy
8,041
+2,718
+51% +$137K 0.2% 189
2018
Q2
$289K Buy
+5,323
New +$283K 0.27% 164
2016
Q3
Sell
-31,300
Closed -$907K 235
2016
Q2
$907K Buy
+31,300
New +$951K 0.4% 84

Other funds holding SNV

Sciencast Management's SNV Position: Q3 2025 in Review

Sciencast Management sold out of Synovus (SNV) in Q3 2025, closing a stake of 12,630 shares — an estimated $654K sold.

Sciencast Management first reported a position in SNV in Q2 2016 and held it in 9 quarters. The position peaked at $1.43M in Q1 2019. 486 funds tracked by Wall St. Rank hold SNV as of Q3 2025.

  • Sciencast Management reported no remaining Synovus position as of Q3 2025 after selling out during the quarter.
  • Sciencast Management sold 12,630 Synovus shares in Q3 2025, an estimated $654K.
  • Sciencast Management first reported a position in Synovus in Q2 2016 and held it in 9 quarters.
  • Sciencast Management's Synovus position peaked at $1.43M in Q1 2019.
  • 486 funds tracked by Wall St. Rank held Synovus as of Q3 2025.

Based on Sciencast Management's 13F filing for Q3 2025, filed 12 Nov 2025.